Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Juan Vera

Juan Vera is recorded as CEO, Board Member and COO at Marker Therapeutics, Inc. (MRKR). Marker Therapeutics, Inc. reported in an 8-K filed November 20, 2023 that Juan Vera was appointed Principal Financial and Accounting Officer, effective November 17, 2023. The proxy statement of Marker Therapeutics, Inc. reports total compensation of $741,190 for Juan Vera in fiscal 2025, including a base salary of $415,385. Disclosed compensation is on record for 4 fiscal years.

“Juan Vera, the Company’s President and Chief Executive Officer, was appointed as the Company’s Principal Financial and Accounting Officer.”
Marker Therapeutics, Inc. Form 8-K, filed November 20, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Marker Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Marker Therapeutics, Inc. (MRKR) $415,385 $741,190
2024 Marker Therapeutics, Inc. (MRKR) $400,000 $400,000
2023 Marker Therapeutics, Inc. (MRKR) $399,251 $581,923
2022 Marker Therapeutics, Inc. (MRKR) $379,981 $581,923

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.